Annual Total Liabilities
$1.30 M
-$2.97 M-69.55%
December 31, 2023
Summary
- As of February 12, 2025, SLRX annual total liabilities is $1.30 million, with the most recent change of -$2.97 million (-69.55%) on December 31, 2023.
- During the last 3 years, SLRX annual total liabilities has fallen by -$1.47 million (-53.15%).
- SLRX annual total liabilities is now -96.92% below its all-time high of $42.15 million, reached on December 31, 2014.
Performance
SLRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$934.60 K
-$243.90 K-20.70%
September 30, 2024
Summary
- As of February 12, 2025, SLRX quarterly total liabilities is $934.60 thousand, with the most recent change of -$243.90 thousand (-20.70%) on September 30, 2024.
- Over the past year, SLRX quarterly total liabilities has dropped by -$299.50 thousand (-24.27%).
- SLRX quarterly total liabilities is now -84.12% below its all-time high of $5.89 million, reached on December 31, 2017.
Performance
SLRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SLRX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.5% | -24.3% |
| 3 y3 years | -53.1% | -74.3% |
| 5 y5 years | +17.4% | -74.3% |
SLRX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.5% | at low | -79.2% | at low |
| 5 y | 5-year | -69.5% | at low | -79.2% | at low |
| alltime | all time | -96.9% | +17.4% | -84.1% | +16.4% |
Salarius Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $934.60 K(-20.7%) |
| Jun 2024 | - | $1.18 M(-4.5%) |
| Mar 2024 | - | $1.23 M(-5.0%) |
| Dec 2023 | $1.30 M(-69.5%) | $1.30 M(-44.0%) |
| Sep 2023 | - | $2.32 M(-36.3%) |
| Jun 2023 | - | $3.64 M(-19.0%) |
| Mar 2023 | - | $4.50 M(+5.4%) |
| Dec 2022 | $4.27 M(+102.1%) | $4.27 M(+37.2%) |
| Sep 2022 | - | $3.11 M(+12.3%) |
| Jun 2022 | - | $2.77 M(+32.4%) |
| Mar 2022 | - | $2.09 M(-0.9%) |
| Dec 2021 | $2.11 M(-23.9%) | $2.11 M(+30.9%) |
| Sep 2021 | - | $1.61 M(+3.8%) |
| Jun 2021 | - | $1.55 M(-21.9%) |
| Mar 2021 | - | $1.99 M(-28.3%) |
| Dec 2020 | $2.77 M(-16.3%) | $2.77 M(+12.9%) |
| Sep 2020 | - | $2.46 M(+44.0%) |
| Jun 2020 | - | $1.71 M(-17.3%) |
| Mar 2020 | - | $2.06 M(-37.7%) |
| Dec 2019 | $3.31 M | $3.31 M(-29.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $4.72 M(+355.6%) |
| Jun 2019 | - | $1.04 M(+13.7%) |
| Mar 2019 | - | $911.10 K(-17.7%) |
| Dec 2018 | $1.11 M(-81.2%) | $1.11 M(-61.7%) |
| Sep 2018 | - | $2.89 M(-24.1%) |
| Jun 2018 | - | $3.80 M(-8.3%) |
| Mar 2018 | - | $4.14 M(-29.6%) |
| Dec 2017 | $5.89 M(+51.0%) | $5.89 M(+17.1%) |
| Sep 2017 | - | $5.03 M(-1.9%) |
| Jun 2017 | - | $5.13 M(+56.4%) |
| Mar 2017 | - | $3.28 M(-15.9%) |
| Dec 2016 | $3.90 M(+35.5%) | $3.90 M(-0.7%) |
| Sep 2016 | - | $3.92 M(+15.0%) |
| Jun 2016 | - | $3.41 M(+10.7%) |
| Mar 2016 | - | $3.08 M(+7.1%) |
| Dec 2015 | $2.88 M(-93.2%) | $2.88 M(+4.2%) |
| Sep 2015 | - | $2.76 M(+8.0%) |
| Jun 2015 | - | $2.56 M(+37.3%) |
| Mar 2015 | - | $1.86 M(+131.9%) |
| Dec 2014 | $42.15 M | - |
| Sep 2014 | - | $803.30 K |
FAQ
- What is Salarius Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual total liabilities year-on-year change?
- What is Salarius Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly total liabilities year-on-year change?
What is Salarius Pharmaceuticals annual total liabilities?
The current annual total liabilities of SLRX is $1.30 M
What is the all time high annual total liabilities for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual total liabilities is $42.15 M
What is Salarius Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, SLRX annual total liabilities has changed by -$2.97 M (-69.55%)
What is Salarius Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of SLRX is $934.60 K
What is the all time high quarterly total liabilities for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly total liabilities is $5.89 M
What is Salarius Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, SLRX quarterly total liabilities has changed by -$299.50 K (-24.27%)